Composiciones que comprenden anticuerpos humanizados contra ligandos de tipo tnf 1a (tl1a) y sus usos
En el presente documento, se describen anticuerpos humanizados anti-TL1A y composiciones farmacéuticas para el tratamiento de enfermedades inflamatorias intestinales (IBD), tales como la enfermedad de Crohn (CD) y colitis ulcerosa (UC). Described herein are humanized anti-TL1A antibodies and pharmac...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | spa |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | LAURENT, Olivier PAYNE, Robert TARGAN, Stephan R MANNING, Mark OTSUKI, Lauren BILSBOROUGH, Janine LUO, Allison HENKLE, Bradley |
| description | En el presente documento, se describen anticuerpos humanizados anti-TL1A y composiciones farmacéuticas para el tratamiento de enfermedades inflamatorias intestinales (IBD), tales como la enfermedad de Crohn (CD) y colitis ulcerosa (UC).
Described herein are humanized anti-TL1A antibodies and pharmaceutical compositions for the treatment of inflammatory bowel disease (IBD), such as Crohn's Disease (CD) and ulcerative colitis (UC). |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CO2023011969A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CO2023011969A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CO2023011969A23</originalsourceid><addsrcrecordid>eNqNijEKwkAQRdNYiHqHARsthGwCQkoJip2NfRh2J2YhmVkzu4We3hU8gNX77_OWBbUyBVFvvTApPBOBzc9M7IgBOXqbaM4FDGlC9m90eVvhOCOM_oH8dUcQfRCI3INB2MXR4B5eoEkhqei6WPQ4Km1-XBXby_neXg8UpCMNaIkpdu2tKqu6NKY5Nqeq_q_6ACq7P5E</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Composiciones que comprenden anticuerpos humanizados contra ligandos de tipo tnf 1a (tl1a) y sus usos</title><source>esp@cenet</source><creator>LAURENT, Olivier ; PAYNE, Robert ; TARGAN, Stephan R ; MANNING, Mark ; OTSUKI, Lauren ; BILSBOROUGH, Janine ; LUO, Allison ; HENKLE, Bradley</creator><creatorcontrib>LAURENT, Olivier ; PAYNE, Robert ; TARGAN, Stephan R ; MANNING, Mark ; OTSUKI, Lauren ; BILSBOROUGH, Janine ; LUO, Allison ; HENKLE, Bradley</creatorcontrib><description>En el presente documento, se describen anticuerpos humanizados anti-TL1A y composiciones farmacéuticas para el tratamiento de enfermedades inflamatorias intestinales (IBD), tales como la enfermedad de Crohn (CD) y colitis ulcerosa (UC).
Described herein are humanized anti-TL1A antibodies and pharmaceutical compositions for the treatment of inflammatory bowel disease (IBD), such as Crohn's Disease (CD) and ulcerative colitis (UC).</description><language>spa</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230929&DB=EPODOC&CC=CO&NR=2023011969A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230929&DB=EPODOC&CC=CO&NR=2023011969A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LAURENT, Olivier</creatorcontrib><creatorcontrib>PAYNE, Robert</creatorcontrib><creatorcontrib>TARGAN, Stephan R</creatorcontrib><creatorcontrib>MANNING, Mark</creatorcontrib><creatorcontrib>OTSUKI, Lauren</creatorcontrib><creatorcontrib>BILSBOROUGH, Janine</creatorcontrib><creatorcontrib>LUO, Allison</creatorcontrib><creatorcontrib>HENKLE, Bradley</creatorcontrib><title>Composiciones que comprenden anticuerpos humanizados contra ligandos de tipo tnf 1a (tl1a) y sus usos</title><description>En el presente documento, se describen anticuerpos humanizados anti-TL1A y composiciones farmacéuticas para el tratamiento de enfermedades inflamatorias intestinales (IBD), tales como la enfermedad de Crohn (CD) y colitis ulcerosa (UC).
Described herein are humanized anti-TL1A antibodies and pharmaceutical compositions for the treatment of inflammatory bowel disease (IBD), such as Crohn's Disease (CD) and ulcerative colitis (UC).</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNijEKwkAQRdNYiHqHARsthGwCQkoJip2NfRh2J2YhmVkzu4We3hU8gNX77_OWBbUyBVFvvTApPBOBzc9M7IgBOXqbaM4FDGlC9m90eVvhOCOM_oH8dUcQfRCI3INB2MXR4B5eoEkhqei6WPQ4Km1-XBXby_neXg8UpCMNaIkpdu2tKqu6NKY5Nqeq_q_6ACq7P5E</recordid><startdate>20230929</startdate><enddate>20230929</enddate><creator>LAURENT, Olivier</creator><creator>PAYNE, Robert</creator><creator>TARGAN, Stephan R</creator><creator>MANNING, Mark</creator><creator>OTSUKI, Lauren</creator><creator>BILSBOROUGH, Janine</creator><creator>LUO, Allison</creator><creator>HENKLE, Bradley</creator><scope>EVB</scope></search><sort><creationdate>20230929</creationdate><title>Composiciones que comprenden anticuerpos humanizados contra ligandos de tipo tnf 1a (tl1a) y sus usos</title><author>LAURENT, Olivier ; PAYNE, Robert ; TARGAN, Stephan R ; MANNING, Mark ; OTSUKI, Lauren ; BILSBOROUGH, Janine ; LUO, Allison ; HENKLE, Bradley</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CO2023011969A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>LAURENT, Olivier</creatorcontrib><creatorcontrib>PAYNE, Robert</creatorcontrib><creatorcontrib>TARGAN, Stephan R</creatorcontrib><creatorcontrib>MANNING, Mark</creatorcontrib><creatorcontrib>OTSUKI, Lauren</creatorcontrib><creatorcontrib>BILSBOROUGH, Janine</creatorcontrib><creatorcontrib>LUO, Allison</creatorcontrib><creatorcontrib>HENKLE, Bradley</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LAURENT, Olivier</au><au>PAYNE, Robert</au><au>TARGAN, Stephan R</au><au>MANNING, Mark</au><au>OTSUKI, Lauren</au><au>BILSBOROUGH, Janine</au><au>LUO, Allison</au><au>HENKLE, Bradley</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Composiciones que comprenden anticuerpos humanizados contra ligandos de tipo tnf 1a (tl1a) y sus usos</title><date>2023-09-29</date><risdate>2023</risdate><abstract>En el presente documento, se describen anticuerpos humanizados anti-TL1A y composiciones farmacéuticas para el tratamiento de enfermedades inflamatorias intestinales (IBD), tales como la enfermedad de Crohn (CD) y colitis ulcerosa (UC).
Described herein are humanized anti-TL1A antibodies and pharmaceutical compositions for the treatment of inflammatory bowel disease (IBD), such as Crohn's Disease (CD) and ulcerative colitis (UC).</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | spa |
| recordid | cdi_epo_espacenet_CO2023011969A2 |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Composiciones que comprenden anticuerpos humanizados contra ligandos de tipo tnf 1a (tl1a) y sus usos |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T03%3A19%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LAURENT,%20Olivier&rft.date=2023-09-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECO2023011969A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |